Gossamer Bio vs Siga Technologies
Siga Technologies is the larger business, with $94.6m of revenue in fiscal 2025 against $48.5m for Gossamer Bio (2.0 times as much). Siga Technologies grew faster (-31.8% against -57.7%). Siga Technologies kept more of each dollar of sales as profit: a net margin of 24.6% against -351.5%.
| Latest fiscal year | Gossamer BioGOSS, 2025 | Siga TechnologiesSIGA, 2025 |
|---|---|---|
| Revenue | $48.5m | $94.6m |
| Revenue growth | -57.7% | -31.8% |
| Net income | −$170m | $23.3m |
| Operating margin | -352.2% | 25.1% |
| Net margin | -351.5% | 24.6% |
| Return on equity | — | 11.2% |
| Free cash flow | −$171m | $43.1m |
| Cash | $37.7m | $155m |
| Total debt | $0 | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | $0.60 |
| Dividend yield | — | — |
| Share buybacks | — | $0 |
| Employees | 161 | 49 |
| Market value | $4.41bn | $222m |
| Price vs our value range | — | Below our value range |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | — |